1048366-26-2

Upstream product

• 1048367-39-0 (S)-N-(2-((4-fluorobenzyl)(methyl)amino)-2-oxo-1-phenylethyl)-6-nitrobenzo[d]thiazole-2-carboxamide 

Downstream Products

• 1048366-31-9 (S)-N-(2-((4-fluorobenzyl)(methyl)amino)-2-oxo-1-phenylethyl)-6-(2-(imidazo[2,1-b]thiazol-6-yl)benzamido)benzo[d]thiazole-2-carboxamide 
• 1107646-56-9 (S)-6-(5-(4-tert-butylphenyl)thiazole-4-carboxamido)-N-(2-((4-fluorobenzyl)(methyl)amino)-2-oxo-1-phenylethyl)benzo[d]thiazole-2-carboxamide 
• 1107646-54-7 (S)-6-(2-(4-tert-butylphenyl)nicotinamido)-N-(2-((4-fluorobenzyl)(methyl)amino)-2-oxo-1-phenylethyl)benzo[d]thiazole-2-carboxamide 
• 1048366-77-3 (S)6-(2-(4-tert-butylthiazol-2-yl)benzanilido)-N-(2-((4-fluorobenzyl)(methyl)amino)-2-oxo-1-phenylethyl)benzo[d]thiazole-2-carboxamide 

Relevant academic research and scientific papers

HETEROCYCLYLAMIDES AS GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS

Compounds represented by formula (I) are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.

GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS

Compounds represented by formula (I): are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.